BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24405450)

  • 1. Apoptosis-inducing agents: a patent review (2010 - 2013).
    Kamal A; Faazil S; Malik MS
    Expert Opin Ther Pat; 2014 Mar; 24(3):339-54. PubMed ID: 24405450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule inhibitors of PIM1 kinase: July 2009 to February 2013 patent update.
    Arunesh GM; Shanthi E; Krishna MH; Sooriya Kumar J; Viswanadhan VN
    Expert Opin Ther Pat; 2014 Jan; 24(1):5-17. PubMed ID: 24131033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor inhibitors: a patent review (2010 - present).
    Li SN; Li HQ
    Expert Opin Ther Pat; 2014 Mar; 24(3):309-21. PubMed ID: 24387079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tubulin inhibitors: a patent review.
    Liu YM; Chen HL; Lee HY; Liou JP
    Expert Opin Ther Pat; 2014 Jan; 24(1):69-88. PubMed ID: 24313741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-MET kinase inhibitors: a patent review (2011 - 2013).
    Zhu K; Kong X; Zhao D; Liang Z; Luo C
    Expert Opin Ther Pat; 2014 Feb; 24(2):217-30. PubMed ID: 24266843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to Ras signaling modulation and treatment of Ras-dependent disorders: a patent review (2007--present).
    Sacco E; Spinelli M; Vanoni M
    Expert Opin Ther Pat; 2012 Nov; 22(11):1263-87. PubMed ID: 23009088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer therapeutics: Targeting the apoptotic pathway.
    Khan KH; Blanco-Codesido M; Molife LR
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):200-19. PubMed ID: 24507955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-apoptotic proteins-targets for chemosensitization of tumor cells and cancer treatment.
    Kostanová-Poliaková D; Sabová L
    Neoplasma; 2005; 52(6):441-9. PubMed ID: 16284687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PARP inhibitors in cancer therapy: an update.
    Papeo G; Casale E; Montagnoli A; Cirla A
    Expert Opin Ther Pat; 2013 Apr; 23(4):503-14. PubMed ID: 23379721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline derivatives as potential anticancer agents: a patent review (2007 - 2010).
    Marzaro G; Guiotto A; Chilin A
    Expert Opin Ther Pat; 2012 Mar; 22(3):223-52. PubMed ID: 22404097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment.
    Beesoo R; Neergheen-Bhujun V; Bhagooli R; Bahorun T
    Mutat Res; 2014 Oct; 768():84-97. PubMed ID: 24685981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of JAK2 and JAK3: an update on the patent literature 2010 - 2012.
    Dymock BW; See CS
    Expert Opin Ther Pat; 2013 Apr; 23(4):449-501. PubMed ID: 23367873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirtuin modulators: an updated patent review (2012 - 2014).
    Mellini P; Valente S; Mai A
    Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective cannabinoid receptor 2 modulators: a patent review 2009--present.
    Riether D
    Expert Opin Ther Pat; 2012 May; 22(5):495-510. PubMed ID: 22537079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendrimer and cancer: a patent review (2006-present).
    Cai X; Hu J; Xiao J; Cheng Y
    Expert Opin Ther Pat; 2013 Apr; 23(4):515-29. PubMed ID: 23339480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Bcl-2 in tumour cell survival and implications for pharmacotherapy.
    Tomek M; Akiyama T; Dass CR
    J Pharm Pharmacol; 2012 Dec; 64(12):1695-702. PubMed ID: 23146031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directing cancer cells to self-destruct with pro-apoptotic receptor agonists.
    Ashkenazi A
    Nat Rev Drug Discov; 2008 Dec; 7(12):1001-12. PubMed ID: 18989337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis modulators as cancer therapeutics.
    Penn LZ
    Curr Opin Investig Drugs; 2001 May; 2(5):684-92. PubMed ID: 11569948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding the cell death pathways activated by anticancer therapy.
    Kim R
    Cancer; 2005 Apr; 103(8):1551-60. PubMed ID: 15742333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming resistance of cancer cells to apoptosis.
    Hersey P; Zhang XD
    J Cell Physiol; 2003 Jul; 196(1):9-18. PubMed ID: 12767037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.